07.01.2018 15:50:22
|
New Drugs Approved In December
(RTTNews) - The process of drug development is challenging. Some drugs pass the FDA muster easily, while some face a host of hurdles before getting the official stamp of approval.
Last month, 6 novel drugs were approved, making the total number of novel drug approvals for 2017 to 46. This number compares favorably with 2016, which saw just 22 novel drugs getting the regulatory nod. Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.
Here's the list of new drugs, including novel drugs and biosimilars, which were approved in December 2017.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Spark Therapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Spark Therapeutics Incmehr Analysen
Aktien in diesem Artikel
Aclaris Therapeutics Inc | 2,57 | 4,26% | |
Johnson & Johnson | 139,92 | -0,26% | |
Merck Co. | 96,00 | -0,41% | |
Novo Nordisk (spons. ADRs) | 84,20 | -2,09% | |
Pfizer Inc. | 25,84 | -0,39% | |
Sanofi S.A. (spons. ADRs) | 46,80 | 0,86% | |
Sanofi S.A. | 93,25 | -0,61% |